from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1609/trpE

LFCtreatmentdescriptionclass of inhibitor

-0.673

Amikacinug/mL Amikacintranslation

0.824

Cap5-10ug/mL Capreomycintranslation

1.198

Rox10-50 ug/mL Roxithromycintranslation

0.673

SM2-5 ug/mL Streptomycintranslation

-0.582

Tet5-10 ug/mL Tetracyclinetranslation

-0.626

Rif0.2-5ug/mL Rifampicintranscription

0.062

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.255

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.150

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.082

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.484

Clofazimine10-13 ug/mL Clofaziminerespiration

0.576

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.578

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.891

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.561

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.151

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.945

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.340

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.296

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.382

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.056

KCN5-20 ug/mL Potassium cyaniderespiration

1.847

NaN30.2-2 mM Sodium aziderespiration

0.711

Nigericin50 uM Nigericinrespiration

-1.412

TRC10-150 ug/mL Triclosanrespiration

-1.199

TRZ10-25 ug/mL Thioridazinerespiration

1.014

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.802

menadione6-10 ug/mL Menadionerespiration

0.009

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.082

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.343

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.786

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.444

NRP_1Non-replicating persistence stage 1dosRassociated

-0.271

Amp0.2mg/mL AmpicillincellWall

0.451

Cephalexin20-100 ug/mL CephalexincellWall

0.557

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.334

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.525

EMB10-20 ug/mL EthambutolcellWall

0.533

Eta12-40 ug/mL EthionamidecellWall

0.586

INH0.2-0.4 ug/mL IsoniazidcellWall

0.910

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.110

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.570

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.052

BZA0.12 mg/mL BenzamidearomaticAmides

-0.173

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.072

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.072

H2O24 mM hydrogen peroxideDNAdamaging

0.361

Levo10 ug/mL LevofloxacinDNAdamaging

0.227

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.254

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.503

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.038

UVUV-irradiationDNAdamaging

-0.714

ARP41-4 ug/mL Antitubercular compound ARP4?

0.377

Antimycin12.5-50 ug/mL Antimycin A?

0.364

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.867

PA_110-50 ug/mL Antitubercular compound PA-1?

0.338

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.231

PA8240.2-2 ug/mL PA-824?

0.798

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.430

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.010

Verapamil50 uM Verapamil?

0.122

mercaptoethanol2 mM 2-Mercaptoethanol?

0.648

methoxatin10-20 ug/mL Methoxatin?